Clinical trial

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

NCT02043054

Study summary

ClinicalTrials.gov

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Liraglutide Normalized identity: liraglutide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sitagliptin Normalized identity: sitagliptin View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-16

PhasePHASE3

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Cardiovascular Diseaseverified · MONDO: cardiovascular disorder

Interventions

LiraglutideDRUG · verified · RxNorm: liraglutide

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

University of Leicesterlead sponsor

Novo Nordisk A/Scollaborator

University Hospitals, Leicestercollaborator

Mapped research locations

LeicesterLeicestershire, United Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02043054 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.